Pancreatic Cancer Research

ResearcherAmsterdam University Medical CentersActive in the last 2 years

Mark P.G. Dings

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8509-0006; OpenAlex author ID A5008096531. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
42
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 7

  1. Estrogen Production in Pancreatic Cancer Shapes a Tumor-Suppressive Stromal Microenvironment. Co-author DOI 10.1158/0008-5472.can-24-4707↗
  2. KRAS mutation status integrated with RNA subtyping improves prognostic modeling in FOLFIRINOX-treated metastatic pancreatic cancer. First author DOI 10.1016/j.medj.2025.100601↗
  3. Transcriptome-based classification to predict FOLFIRINOX response in a real-world metastatic pancreatic cancer cohort. First author DOI 10.1016/j.trsl.2024.08.002↗
  4. Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer. Co-author DOI 10.1002/ijc.34276↗
  5. Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study. Co-author DOI 10.1093/bjs/znac272↗
  6. Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classificati… Co-author DOI 10.1038/s41598-019-56826-9↗
  7. CCAAT/Enhancer-Binding Protein Delta (C/EBPδ): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcino… Co-author DOI 10.3390/cancers12092546↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maarten F. Bijlsma · 7 shared papers, 2020–2026 · strength 1.07
  2. Hanneke W.M. van Laarhoven · 6 shared papers, 2020–2026 · strength 0.97
  3. Marjolein F. Lansbergen · 3 shared papers, 2024–2026 · strength 0.64
  4. Johanna W. Wilmink · 3 shared papers, 2024–2026 · strength 0.64
  5. Paul Manoukian · 3 shared papers, 2023–2026 · strength 0.56
  6. Frederike Dijk · 4 shared papers, 2020–2024 · strength 0.47
  7. Marc G. Besselink · 4 shared papers, 2020–2023 · strength 0.42
  8. Joanne Verheij · 3 shared papers, 2020–2024 · strength 0.38
  9. Izaak Quintus Molenaar · 2 shared papers, 2022–2023 · strength 0.25
  10. Bert A. Bonsing · 2 shared papers, 2022–2023 · strength 0.25
  11. Marin Strijker · 2 shared papers, 2022–2023 · strength 0.25
  12. Nienke Petronella Maria Wassenaar · 1 shared paper, 2026 · strength 0.24
  13. Geert Kazemier M · 1 shared paper, 2026 · strength 0.24
  14. Judith de Vos‐Geelen · 1 shared paper, 2025 · strength 0.22
  15. Marjolein Y.V. Homs · 1 shared paper, 2025 · strength 0.22
  16. Louis Vermeulen · 2 shared papers, 2020–2023 · strength 0.21
  17. Eline C. Soer · 2 shared papers, 2020–2022 · strength 0.19
  18. Sophie C. Lodestijn · 1 shared paper, 2023 · strength 0.14
  19. Nadia Haj Mohammad · 1 shared paper, 2023 · strength 0.14
  20. Michail Doukas · 1 shared paper, 2023 · strength 0.14
  21. Ignace H. J. T. de Hingh · 1 shared paper, 2023 · strength 0.14
  22. Marco J. Bruno · 1 shared paper, 2023 · strength 0.14
  23. Casper H.J. van Eijck · 1 shared paper, 2023 · strength 0.14
  24. Hans Morreau · 1 shared paper, 2022 · strength 0.12
  25. Jesse V. Groen · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.